Cytoplasmic localization of NURR1 is associated with decreased patient survival in bladder cancer patients while expression of NURR1 allowed HeLa retrovertant cell lines to regain tumorigenicity[19,20]. The gene discussed is NR4A2; the disease is urinary bladder cancer.